5-Azacitidine has limited therapeutic activity in myelofibrosis.
Mesa RA, Verstovsek S, Rivera C, Pardanani A, Hussein K, Lasho T, Wu W, Tefferi A.
Mesa RA, et al. Among authors: hussein k.
Leukemia. 2009 Jan;23(1):180-2. doi: 10.1038/leu.2008.136. Epub 2008 May 29.
Leukemia. 2009.
PMID: 18509350
Free PMC article.
Clinical Trial.
No abstract available.